6:17 PM
 | 
Sep 28, 2012
 |  BC Extra  |  Top Story

Japan approves Seebri

Japan's Ministry of Health, Labor and Welfare (MHLW) approved Seebri glycopyrronium bromide Inhalation Capsules ( NVA237) from Novartis AG (NYSE:NVS; SIX:NOVN) as a once-daily inhaled maintenance bronchodilator treatment for chronic obstructive...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >